A randomized, double-blind, phase III non-inferiority clinical trial to assess efficacy and safety of triamcinolone acetonide nasal spray in comparison with fluticasone propionate nasal spray in adults suffering from perennial allergic rhinitis (PAR) in Russia: a post-hoc analysis of Quality of Life
Alexander V. Karaulov,
Tamara Vylegzhanina,
Andrey Ovchinnikov,
Nataiya Nenasheva,
Aleksandr Maslakov
Affiliations
Alexander V. Karaulov
I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation
Tamara Vylegzhanina
National Research Center Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russian Federation
Andrey Ovchinnikov
A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russian Federation
Nataiya Nenasheva
Russian Medical Academy of Postdiploma Education, Moscow, Russian Federation
